Advertisement

Topics

Broken drug markets in infectious diseases: Opportunities outside the private sector?

08:00 EDT 11th April 2019 | BioPortfolio

Summary of "Broken drug markets in infectious diseases: Opportunities outside the private sector?"

A subset of anti-infective drugs are increasingly unavailable for patients in the United States due to pricing or withdrawal from the market. Timely market solutions are needed. We assert that solutions to ensure access to some essential anti-infective agents lie outside capital markets and that public-private partnerships may be the most viable solution.

Affiliation

Journal Details

This article was published in the following journal.

Name: PLoS neglected tropical diseases
ISSN: 1935-2735
Pages: e0007190

Links

DeepDyve research library

PubMed Articles [18005 Associated PubMed Articles listed on BioPortfolio]

Therapeutic drug monitoring; the need for practical guidance.

Repurposing Drugs Based on Evolutionary Relationships Between Targets of Approved Drugs and Proteins of Interest.

Drug repurposing has garnered much interest as an effective method for drug development among biopharmaceutical companies. The availability of information on complete sequences of genomes and their as...

Clinical Practice Variation Among Adult Infectious Diseases Physicians in the Management of Staphylococcus aureus Bacteremia.

Infectious disease management of Staphylococcus aureus bacteremia (SAB) was surveyed through the Emerging Infections Network. While there were areas of consensus, we found substantial practice variati...

HIV viral suppression after transition from having no healthcare coverage and relying on Ryan White HIV/AIDS Program Support to Medicaid or private health insurance.

Among 1,942 persons with HIV without healthcare coverage 2012-2015, transitioning to Medicaid (adjusted prevalence ratio 0.95 [0.87, 1.04]) or to private health insurance (1.04 [0.95, 1.13]) was not a...

Developing a Career in Pediatric Infectious Diseases.

This article presents an overview of the Career Development session at the 17th Annual St. Jude/PIDS Pediatric Infectious Diseases Research Conference. This annual conference discusses key academic sk...

Clinical Trials [6374 Associated Clinical Trials listed on BioPortfolio]

A Pathology Reference Laboratory for the Study of Infectious Diseases and Malignant Lymphoma

1. To establish a pathology reference laboratory for the consultation on the diagnosis of infectious diseases and lymphoma. 2. To study the specific pathogens on 100 cases of unexp...

Population Pharmacokinetics of Meropenem and Linezolid in Children With Severe Infectious Diseases

This study is based on the hypothesis that the pharmacokinetics of meropenem and linezolid in severe infectious children are different from mild infectious children and adults. The investi...

Diagnosis and Management of Inflammatory and Infectious Diseases

This protocol is being established to cover the admission of patients with inflammatory and/or infectious diseases which are not covered under previously existing protocols. The purpose o...

FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis

Drug-resistant tuberculosis is becoming a major problem for the whole humanity, and development of new Anti-TB drugs is of great importance. Since Kazakhstan is a country with the high bur...

Immune Responses to Antigens in Non-infectious Eye Inflammatory Diseases

This study will collect blood samples from patients with non-infectious eye inflammatory diseases a spectrum of eye disorders that can produce sight-threatening vision loss. The blood ...

Medical and Biotech [MESH] Definitions

A stand-alone drug plan offered by insurers and other private companies to beneficiaries that receive their Medicare Part A and/or B benefits through the Original Medicare Plan. It includes Medicare Private Fee-for-Service Plans that do not offer prescription drug coverage and Medicare Cost Plans offering Medicare prescription drug coverage. The plan was enacted as the Medicare Prescription Drug, Improvement and Modernization Act of 2003 with coverage beginning January 1, 2006.

A component of the private sector characterized by ease of entry; reliance on indigenous resources; family ownership; small scale operations; skills acquired outside of the formal sector; and unregulated markets.

Component of the NATIONAL INSTITUTES OF HEALTH. It conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. It was established in 1948.

A long-acting dopamine agonist which has been used to treat PARKINSON DISEASE and HYPERPROLACTINEMIA but withdrawn from some markets due to potential for HEART VALVE DISEASES.

A branch of internal medicine concerned with the diagnosis and treatment of INFECTIOUS DISEASES.

Advertisement
Quick Search
Advertisement
Advertisement

 


DeepDyve research library

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Searches Linking to this Article